The efficacy of botulinum toxin A in nose reshaping

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20190207002

Enrollment

Registered

2019-02-07

Start date

2019-02-21

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers Age 18&#45

Interventions

Injecting Botulinum toxin type A into procerus&#44

nasalis and depressor nasi muscles

Experimental Drug

Botulinum toxin type A injection

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age 18-60 years No history of nose surgery

Exclusion criteria

Exclusion criteria: Botulinum toxin injection in nasal area within 6 months any health problems in nasal area eg. sinusitis

Design outcomes

Primary

Measure	Time frame
Nasal alar base reduction 3 months imaging and clinical evaluation	—

Secondary

Measure	Time frame
wrinkle reduction 3 months imaging and clinical evaluation	—

Countries

Thailand

Contacts

Public ContactMarisa Pongprutthipan

Division of dermatology, Department of medicine, Faculty of Medicine, Chulalongkorn University

dr_marisa@yahoo.com085-3620400

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026